About.com taps WebMD for health exec

Share this article:
About.com upped the ante on its health offering, bringing on Marjorie Martin from archrival WebMD to head About Health (health.about.com). 

Martin, who started out as a TV news correspondent and spent eight years at WebMD, most recently as VP and managing director, is charged with adding features and plotting strategy to expand and differentiate the site. She reports to COO Andrew Pancer. 

With 4.9 million unique visitors in March, according to Nielsen Net Ratings, About Health lags behind WebMD (22.6 million) and MSN Health (5.7 million), but leads both AOL Health (4 million) and Yahoo! Health (2.8 million). 

About.com president and CEO Scott Meyer said the site is the strongest of the About.com properties, recently bought by The New York Times Company, and that the firm sought to leverage its expertise and original content to pull ahead of the portals.

“What we really have is two sites [About and WebMD] publishing quality original content, and the portals are really just aggregating content from elsewhere,” said Meyer. About Health, he said, projects the “voice of reason,” with credentialed expert guides trained by the company and paid based on the traffic their sites generate. 

Meyer said the sector had seen sharp growth in online advertising spending recently, from pharmas as well as from device manufacturers and consumer packaged-goods companies.
Share this article:
close

Next Article in News

Email Newsletters

More in News

Five things for pharma marketers to know: Friday, August 22

Five things for pharma marketers to know: Friday, ...

Two new indications give Eliquis more juice, a new rule is making hydrocodone harder to get and the ALS Ice Bucket Challenge highlights a controversial aspects of drug discovery and ...

Lilly takes on Amgen's Enbrel

Lilly takes on Amgen's Enbrel

Phase-III tests indicate Lilly's experimental treatment bests Amgen's for moderate-to-severe plaque psoriasis.

GSK Ellipta franchise expands

GSK Ellipta franchise expands

The FDA has approved Arnuity Ellipta for asthma.